The global Peripheral Neuropathy Market was valued at USD 1.48 billion in 2023 and is projected to surpass USD 2.38 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.46% during the forecast period from 2024 to 2032. The rising incidence of diabetes, cancer, and other chronic diseases, coupled with advancements in treatment options, are driving significant growth in this marke..
